Ontology highlight
ABSTRACT: Aim
Our aim was to ascertain whether metformin can reduce insulin requirement without compromising glycaemic control during pregnancy in women with type 1 diabetes.Methods
A total of 126 pregnant women with type 1 diabetes were recruited for a randomised, double-blind, placebo-controlled multicentre study. The primary outcome was total insulin change, defined as the difference between baseline and third trimester maximum insulin dose (IU).Results
Fifty women in the placebo group and 51 women in the metformin group completed the study. A predetermined sample size of 200 participants was not achieved. There was no significant difference in the primary outcome, that is, in the change of total insulin requirement (33 vs. 27 IU, p = 0.193). However, the metformin group s
SUBMITTER: Juuma E
PROVIDER: S-EPMC12415408 | biostudies-literature | 2025 Sep
REPOSITORIES: biostudies-literature